Unknown

Dataset Information

0

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.

ABSTRACT:

SUBMITTER: Shah V 

PROVIDER: S-EPMC7307054 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown DNMT3A in haematological malignancies.
| S-EPMC5814392 | biostudies-literature
Unknown Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
| S-EPMC8366163 | biostudies-literature
Other King's college
| EGAO00000000724 | EGA
Unknown Haematological malignancies: at the forefront of immunotherapeutic innovation.
| S-EPMC4511812 | biostudies-literature
Unknown PARP Inhibitors and Haematological Malignancies-Friend or Foe?
| S-EPMC8582507 | biostudies-literature
Unknown Shared-care model for complex chronic haematological malignancies.
| S-EPMC8128424 | biostudies-literature
Unknown Recent advances in T-cell immunotherapy for haematological malignancies.
| S-EPMC5318250 | biostudies-literature
Unknown The Application of CAR-T Cells in Haematological Malignancies.
| S-EPMC7647970 | biostudies-literature
Unknown Asbestos exposure and haematological malignancies: a Danish cohort study.
| S-EPMC7524705 | biostudies-literature
Unknown Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.
| S-EPMC1383661 | biostudies-other